US Generic drug user fee reauthorization negotiations are close to completion after nearly 11 months, with the ratification and Capitol Hill phases of the process upcoming.
Minutes of a 29 July meeting indicated that industry and US Food and Drug Administration officials discussed the draft...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?